lumigan 0.1 mg/ml, collyre en solution
abbvie ag - bimatoprostum - 0.1 mg/ml, collyre en solution - bimatoprostum 0.1 mg, benzalkonii chloridum 200 µg, dinatrii phosphas heptahydricus corresp. phosphas 0.95 mg, acidum citricum monohydricum, natrii chloridum, acidum hydrochloridum aut natrii hydroxidum ad ph, aqua purificata, ad solutionem pro 1 ml. - le glaucome - synthetika
lumigan 0,3 mg/ml unit dose collyre
abbvie ag - bimatoprostum - collyre - bimatoprostum 0.3 mg, dinatrii phosphas heptahydricus corresp. phosphas 0.95 mg, acidum citricum monohydricum, natrii chloridum, acidum hydrochloridum aut natrii hydroxidum ad ph, aqua purificata, ad solutionem pro 1 ml. - le glaucome - synthetika
lumigan solution
allergan inc - bimatoprost - solution - 0.03% - bimatoprost 0.03% - prostaglandin analogs
vistitan solution
sandoz canada incorporated - bimatoprost - solution - 0.03% - bimatoprost 0.03% - prostaglandin analogs
latisse solution
abbvie corporation - bimatoprost - solution - 0.03% - bimatoprost 0.03% - prostaglandin analogs
apo-bimatoprost solution
apotex inc - bimatoprost - solution - 0.03% - bimatoprost 0.03% - prostaglandin analogs
lumigan pf solution
allergan inc - bimatoprost - solution - 0.03% - bimatoprost 0.03% - prostaglandin analogs
apo-bimatoprost solution
apotex inc - bimatoprost - solution - 0.03% - bimatoprost 0.03% - prostaglandin analogs
bimatoprost labatec 0.1 mg/ml collyre
labatec pharma sa - bimatoprostum - collyre - bimatoprostum 0,1 mg, conserv.: benzalkonii chloridum, excipiens ad solution de 1 ml. - glaucome - synthetika
bimatoprost labatec 0.3 mg/ml collyre
labatec pharma sa - bimatoprostum - collyre - bimatoprostum 0,3 mg, conserv.: benzalkonii chloridum, excipiens ad solution de 1 ml. - glaucome - synthetika